- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$1.03 BnMarket Estimate, 2026
$1.14 BnMarket Forecast, 2034
$2.46 BnCAGR, 2026–2034
10.1%North America Blood Screening Market Size
The North America blood screening market was valued at USD 1.03 billion in 2025 and increased to USD 1.14 billion in 2026. The market is projected to reach USD 2.46 billion by 2034, growing at a CAGR of 10.1% from 2026 to 2034.
A few of the significant factors promoting the blood screening market in the North American region are the vast pool of patients, improved healthcare infrastructure, increasing disposable income, growing demand for donated blood, and growing government support. On the other hand, increasing awareness of the importance of maintaining the safety of donated blood, the rising prevalence of infectious diseases, and the growing demand for donated blood are majorly contributing to the market growth.
In Addition, new technological advancements in blood screening, major market key players, increased healthcare concern, and a rising number of initiators like initiatives taken by the government are expected to propel the market growth.
However, alternative technologies, such as digital immunoassay and a scarcity of qualified workers, are projected to restrain the North American blood screening market growth during the forecast period. Also, the Complex regulatory frameworks for approval, a shortage of experienced labor, competing technologies such as digital immunoassay, and expensive initial capital investment and testing expenses further limit the blood screening market growth.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Technology, Product, End User, and Region. |
| Various Analyses Covered | Global, Regional, and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Countries Covered | The United States |
| Market Leaders Profiled | Becton, Dickinson and Company, Thermo Fisher Scientific Inc, Ortho Clinical Diagnostics, Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche Ltd, Grifols, Siemens AG, and Beckman Coulter, Inc. |
KEY MARKET PLAYERS
A few of the promising companies operating in the North America blood screening market profiled in the report are
Becton, Dickinson and Company, Thermo Fisher Scientific Inc, Ortho Clinical Diagnostics, Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche Ltd, Grifols, Siemens AG and Beckman Coulter, Inc.
MARKET SEGMENTATION
This research report on the North American blood screening market has been segmented and sub-segmented into the following categories
By Technology
- Nucleic Acid Amplification
- Elisa
- Rapid Test
- NGS
- Western Blotting
By Product
- Instruments
- Reagent & Kits
- Software
By End User
- Blood banks
- Hospital
By Country
- The United States
- Canada
- Rest of North America